Search / 43 posts tagged stents

Ureteral StentsI am happy to say that the big ureteral stent is out and I love the new found freedom I am experiencing!I don't know the exact status of my ureter yet other than it is open, but narrow... and the damage is longer than a centimeter and that isn't a good thing.

It seems that this company may never see an end to its cardiovascular stent troubles. Leading medical device maker Boston Scientific looks to be facing renewed strife in overcoming the controversies that surround its interventional cardiology products, which are used to prevent clogged arteries.

medical devices, Boston Scientific, Stents Robert Buderi wrote: An FDA application for a Boston Scientific (NYSE:BSX) coronary stent currently awaiting approval was supported by a flawed statistical equation, according to today’s Wall Street Journal.

Boston Scientific’s new stent is “backed by flawed research,” according to an analysis by the WSJ’s Keith Winstein in this morning’s paper. The WSJ article questions the results of a key trial of the Taxus Liberte stent, which is expected to be approved by the FDA in the coming months.

Drugs as good as stents for many heart patients Headlines from the Associated Press Thu, 08/14/2008 - 06:43 People with chronic chest pain who are not in big danger of a heart attack now may have even less reason to rush into an artery-opening angioplasty: There's more evidence drugs should be tried first and often are just as effective....

SurModics: Investors Looking Under The Hood (SRDX, MRK, JNJ) August 11, 2008 · Filed Under General · Comments Off SurModics Inc. (NASDAQ: SRDX) is seeing a sharp drop after recent news.  Its partner Merck & Co.

Biotech, Devices, Navilyst Luke Timmerman wrote: Much has been written about Boston Scientific’s retrenching, in light of the decline in its business with stents, the tiny wire mesh devices that prop open clogged arteries. Now as Boston Scientific focuses on its core businesses, one of the units that has been spun off has a new name, Navilyst Medical.

Wyeth was issued a new round of subpoeanas over its heartburn med by a grand jury in Massachusetts investigating pricing and marketing activities, according to a filing with the Securities and Exchange Commission. Current and former employees, in fact, have already testified before the grand jury this year.

The safety scare over drug-coated stents may be passing, but they still don’t rule the market quite the way they used to. Some 73% of stents implanted in the U.S. last month were drug-coated models, up from a low of 62% in December, the WSJ reports. But that’s still down from the 88% share they held two years ago.

Good morning, everyone. This is likely to be a short day, because here in the US, the Fourth of July holiday weekend is quickly approaching. For many, this pause in the action may provide an opportunity to reflect on the national state of affairs. We will not recite a litany of problems or attempt to preach.